PMC Articles for PubChem Substance (Select 135025044) - PMC

Result Filters

Links from PubChem Substance

Items: 1 to 20 of 105

<< First< Prev

Page of 6

Select item 47521981.

Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda

Padmini Srikantiah, Maria N. Walusimbi, H. Kose Kayanja, Harriet Mayanja-Kizza, Roy D. Mugerwa, Royce Lin, Edwin D. Charlebois, W. Henry Boom, Christopher C. Whalen, Diane V. Havlir

AIDS. Author manuscript; available in PMC 2016 Feb 12.

Published in final edited form as: AIDS. 2007 Sep 12; 21(14): 1972–1974. doi: 10.1097/QAD.0b013e32823ecf6e

PMCID:: PMC4752198

Abstract Article PDF–95K

Select item 41559232.

Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity

Michael A. Norcross, Shen Luo, Li Lu, Michael T. Boyne, Mary Gomarteli, Aaron D. Rennels, Janet Woodcock, David H. Margulies, Curtis McMurtrey, Stephen Vernon, William H. Hildebrand, Rico Buchli

AIDS. Author manuscript; available in PMC 2014 Sep 5.

Published in final edited form as: AIDS. 2012 Jul 17; 26(11): F21–F29. doi: 10.1097/QAD.0b013e328355fe8f

PMCID:: PMC4155923

Abstract Article PDF–861K

Select item 39103693.

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

Andy I. Choi, Eric Vittinghoff, Steven G. Deeks, Cristin C. Weekley, Yongmei Li, Michael G. Shlipak

AIDS. Author manuscript; available in PMC 2014 Feb 3.

Published in final edited form as: AIDS. 2011 Jun 19; 25(10): 1289–1298. doi: 10.1097/QAD.0b013e328347fa16

PMCID:: PMC3910369

Abstract Article PDF–425K

Select item 38275804.

Pharmacokinetic study of once–daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3–<36 months

Paediatric European Network for Treatment of AIDS (PENTA)

Antivir Ther. Author manuscript; available in PMC 2013 Nov 14.

Published in final edited form as: Antivir Ther. 2010; 15(3): 10.3851/IMP1532. doi: 10.3851/IMP1532

PMCID:: PMC3827580

Abstract Article PDF–681K

Select item 37363195.

Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects

Akil Jackson, Graeme Moyle, Laura Dickinson, David Back, Saye Khoo, Jessica Taylor, Keerti Gedela, George Abongomera, Brian Gazzard, Marta Boffito

Antivir Ther. Author manuscript; available in PMC 2013 Aug 7.

Published in final edited form as: Antivir Ther. 2012; 17(1): 19–24. doi: 10.3851/IMP1910

PMCID:: PMC3736319

Abstract Article PDF–289K

Select item 37244416.

Can Fomepizole be Substituted by Abacavir in the Treatment of Methanol Poisoning?

Hossein Sanaei-Zadeh, Nasim Zamani, Farhad Shahmohammadi

J Med Toxicol. 2011 Jun; 7(2): 179–180. Published online 2011 Apr 12. doi: 10.1007/s13181-011-0154-6

PMCID:: PMC3724441

Article PDF–64K

Select item 36379827.

Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals

Susanna Naggie, Mark S. Sulkowski

Gastroenterology. Author manuscript; available in PMC 2013 May 1.

Published in final edited form as: Gastroenterology. 2012 May; 142(6): 1324–1334.e3. doi: 10.1053/j.gastro.2012.02.012

PMCID:: PMC3637982

Abstract Article PDF–1.6M

Select item 36307548.

Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children

Massimo Cella, Meindert Danhof, Oscar Della Pasqua

Br J Clin Pharmacol. 2012 Aug; 74(2): 346–353. Published online 2012 Jul 10. doi: 10.1111/j.1365-2125.2012.04187.x

PMCID:: PMC3630754

Abstract Article PDF–1.0M

Select item 35846949.

A False Sense of Non-Self

Ellis L. Reinherz

Nature. Author manuscript; available in PMC 2013 Feb 28.

Published in final edited form as: Nature. 2012 Jun 27; 486(7404): 479–481. Published online 2012 Jun 27. doi: 10.1038/486479a

PMCID:: PMC3584694

Abstract Article PDF–516K

Select item 351574910.

Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome

Anuska Llano, Christian Brander

Cell Res. 2012 Dec; 22(12): 1637–1639. Published online 2012 Jul 10. doi: 10.1038/cr.2012.105

PMCID:: PMC3515749

Abstract Article PDF–273K

Select item 351446011.

Inflammatory Biomarkers and Abacavir Use in the Women’s Interagency HIV Study and the Multicenter AIDS Cohort Study

Frank J. Palella, Jr, Stephen J. Gange, Lorie Benning, Lisa Jacobson, Robert C. Kaplan, Alan L. Landay, Russell P. Tracy, Richard Elion

AIDS. Author manuscript; available in PMC 2012 Dec 5.

Published in final edited form as: AIDS. 2010 Jul 17; 24(11): 1657–1665. doi: 10.1097/QAD.0b013e3283389dfa

PMCID:: PMC3514460

Abstract Article PDF–363K

Select item 350506512.

Short Communication: Initiation of an Abacavir-Containing Regimen in HIV-Infected Adults Is Associated with a Smaller Decrease in Inflammation and Endothelial Activation Markers Compared to Non-Abacavir-Containing Regimens

Corrilynn O. Hileman, David A. Wohl, Daniel J. Tisch, Sara M. Debanne, Grace A. McComsey

AIDS Res Hum Retroviruses. 2012 Dec; 28(12): 1561–1564. doi: 10.1089/aid.2012.0034

PMCID:: PMC3505065

Abstract Article PDF–92K

Select item 350499913.

N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo

C Charneira, NM Grilo, SA Pereira, ALA Godinho, EC Monteiro, MM Marques, AMM Antunes

Br J Pharmacol. 2012 Nov; 167(6): 1353–1361. doi: 10.1111/j.1476-5381.2012.02079.x

PMCID:: PMC3504999

Abstract Article PDF–642K

Select item 349979414.

Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women

Iain J MacLeod, Christopher F Rowley, Shahin Lockman, Anthony Ogwu, Sikhulile Moyo, Erik van Widenfelt, Mompati Mmalane, Joseph Makhema, M Essex, Roger L Shapiro

J Int AIDS Soc. 2012; 15(2): 17393. Published online 2012 Jul 10. doi: 10.7448/IAS.15.2.17393

PMCID:: PMC3499794

Abstract Article PDF–456K

Select item 349958415.

In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs

Kyle R. Hukezalie, Naresh R. Thumati, Hélène C. F. Côté, Judy M. Y. Wong

PLoS One. 2012; 7(11): e47505. Published online 2012 Nov 15. doi: 10.1371/journal.pone.0047505

PMCID:: PMC3499584

Abstract Article PDF–911K

Select item 340099916.

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany

E Wolf, M Blankenburg, JR Bogner, W Becker, D Gorriahn, MC Mueller, H Jaeger, R Welte, M Baudewig, R Walli, M Stoll

Eur J Med Res. 2010; 15(4): 145–151. Published online 2010 Apr 8. doi: 10.1186/2047-783X-15-4-145

PMCID:: PMC3400999

Abstract Article PDF–1.1M

Select item 337644017.

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers

Wei Zhao, Massimo Cella, Oscar Della Pasqua, David Burger, Evelyne Jacqz-Aigrain, on behalf of Pediatric European Network for Treatment of AIDS (PENTA) 15 study group

Br J Clin Pharmacol. 2012 Apr; 73(4): 641–650. Published online 2011 Oct 12. doi: 10.1111/j.1365-2125.2011.04121.x

PMCID:: PMC3376440

Abstract Article PDF–1.2M

Select item 337614618.

Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

Hila Haskelberg, Jennifer F. Hoy, Janaki Amin, Peter R. Ebeling, Sean Emery, Andrew Carr, STEAL Study Group

PLoS One. 2012; 7(6): e38377. Published online 2012 Jun 15. doi: 10.1371/journal.pone.0038377

PMCID:: PMC3376146

Abstract Article PDF–294K

Select item 337445919.

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing

MA Martin, TE Klein, BJ Dong, M Pirmohamed, DW Haas, DL Kroetz

Clin Pharmacol Ther. 2012 Apr; 91(4): 734–738. Published online 2012 Feb 29. doi: 10.1038/clpt.2011.355

PMCID:: PMC3374459

Abstract Article PDF–139K

Select item 334666320.

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility

George L. Melikian, Soo-Yon Rhee, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William Towner, Paolo V. Troia-Cancio, Andrew Zolopa, Gregory K. Robbins, Ron Kagan, Dennis Israelski, Robert W. Shafer

Antimicrob Agents Chemother. 2012 May; 56(5): 2305–2313. doi: 10.1128/AAC.05487-11